Next Article in Journal
RNA-Seq Analysis in Non-Small Cell Lung Cancer: What Is the Best Sample from Clinical Practice?
Previous Article in Journal
Cranio-Maxillo-Facial Reconstruction with Polyetheretherketone Patient-Specific Implants: Aesthetic and Functional Outcomes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 14
Issue 8
10.3390/jpm14080850
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Perioperative Modulation of Left Ventricular Systolic Performance: A Retrospective Study on Ionized Calcium and Vitamin D in Cardiac Surgery Patients

by
Adrian Ștef
1,2,3,
Constantin Bodolea
2,
Ioana Corina Bocșan
4,
Alexandru Achim
3,*,
Nadina Tintiuc
1,
Raluca Maria Pop
4,
Aurelia Georgeta Solomonean
1,
Alexandru Manea
5 and
Anca Dana Buzoianu
4
1
Clinical Department of Anesthesia and Intensive Care, Heart Institute “Niculae Stancioiu”, University of Medicine and Pharmacy “Iuliu Hatieganu”, Motilor 19-21, 400001 Cluj-Napoca, Romania
2
Department of Surgery, Discipline of Anesthesia and Intensive Care 2, University of Medicine and Pharmacy “Iuliu Hatieganu”, Victor Babes Nr. 8 Street, 400012 Cluj-Napoca, Romania
3
Cardiology Department, Heart Institute “Niculae Stancioiu”, University of Medicine and Pharmacy “Iuliu Hatieganu”, Motilor 19-21, 400001 Cluj-Napoca, Romania
4
Department of Pharmacology, Toxicology and Clinical Pharmacology, University of Medicine and Pharmacy “Iuliu Hatieganu”, Victor Babes Nr. 8 Street, 400012 Cluj-Napoca, Romania
5
Cardiovascular Surgery Department, Heart Institute “Niculae Stancioiu”, University of Medicine and Pharmacy “Iuliu Hatieganu”, Motilor 19-21, 400001 Cluj-Napoca, Romania
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2024, 14(8), 850; https://doi.org/10.3390/jpm14080850
Submission received: 7 July 2024 / Revised: 4 August 2024 / Accepted: 8 August 2024 / Published: 10 August 2024
(This article belongs to the Section Disease Biomarker)
Browse Figures
Versions Notes

Abstract

:
Background: The perioperative impact of calcium and vitamin D on left ventricular (LV) performance during major cardiac surgery remains unexplored. We aimed to assess the relation of calcium and vitamin D measured at different time points with the LV ejection fraction (EF), and to investigate whether changes in EF correlate with postoperative outcomes. Methods: We enrolled 83 patients, in whom ionized calcium was measured before, during, and after surgery (until discharge), vitamin D preoperatively, and EF pre- and postoperatively at 24 h. The postoperative outcomes were cardiopulmonary bypass (CPB) time, aortic cross-clamp time, mechanical ventilation time, vasoactive inotropic score (VIS) (intraoperative, day 0, day 1), and ICU stay time. Results: The mean age was 64.9 ± 8.5 years, with 21 of the patients (25%) having an EF < 50%. The median change from preoperative to postoperative EF was −2.0 (−10.0–0.0) % (p < 0.001). At the baseline, the EF < 50% group had significantly lower preoperative vitamin D levels than the EF ≥ 50% group (p = 0.048). The calcium trend did not differ across the groups. Preoperative EF was significantly associated with CPB time (r = 0.22, p = 0.044) and aortic cross-clamp time (r = 0.24, p = 0.031). Postoperative EF was significantly and inversely associated with intraoperative VIS (r = −0.28, p = 0.009), VIS day 0 (r = −0.25, p = 0.020), VIS day 1 (r = −0.23, p = 0.036), and ICU length of stay (r = −0.22, p = 0.047). Finally, the change in ejection fraction was significantly and inversely associated with CPB time (r = −0.23, p = 0.037), aortic cross-clamp time (r = −0.22, p = 0.044), intraoperative VIS (r = −0.42, p < 0.001), VIS day 0 (r = −0.25, p = 0.024), mechanical ventilation time (r = −0.22, p = 0.047), and ICU length of stay (r = −0.23, p = 0.039). Conclusions: The fluctuations in perioperative ionized calcium levels were not associated with the evolution of LVEF, although preoperative vitamin D levels may affect those with low EF. Correspondingly, a reduced EF significantly impacted all the studied postoperative outcomes. Further investigation into biomarkers affecting cardiac inotropic function is warranted to better understand their significance.

1. Introduction

Low cardiac output syndrome, myocardial infarction, and in-hospital death are significant postoperative complications in cardiac surgery, impacting 8–12% of patients undergoing open-heart procedures [1]. It is crucial to identify the factors that can impact the aforementioned major cardiac and cardiovascular events (MACCEs). Biomarkers have become integral in the landscape of major cardiovascular surgery, offering insights into disease mechanisms, aiding in the diagnosis, and enhancing patient management and outcomes. The aim of biomarker identification in cardiovascular surgery is multifaceted. Primarily, it seeks to improve risk stratification, early detection of postoperative complications, and personalized treatment approaches. By understanding the biological underpinnings of cardiovascular diseases through biomarkers, clinicians can predict adverse events, monitor surgical success, and potentially discover new therapeutic targets [2].
Certain hormones and electrolytes must be in balance for healthy cardiac function [2]. The process of cardioplegia and cardiopulmonary bypass (CPB) leads to disruptions in electrolyte and hormone metabolism, and the transition from CPB to spontaneous heart function is purposely restricted to a short period of time [3]. To terminate CPB, specific cardiac agents, such as inotropes, are required to enhance cardiac function. The choice of inotropic and vasopressor medications depends on the patient’s cardiovascular condition and hemodynamic status [4]. Beta-adrenergic agonists like epinephrine and calcium are commonly used during weaning from CPB and restoration of the ejection fraction (EF) [5]. Calcium and vitamin D, crucial elements in maintaining and regulating normal heart function, play pivotal roles in cardiomyocyte contraction and expansion [5,6,7].
In the context of chronic heart failure, the exact role of calcium remains elusive. Wang et al. discovered a link between low serum calcium and left ventricular systolic dysfunction in patients with coronary artery disease (CAD) [8]. Other studies have suggested an independent association between high serum calcium levels and heart failure [9,10,11]. Within heart cells, structures such as sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) and sarcolemmal Na+/Ca2+ exchanger (NCX1) play crucial roles in maintaining calcium homeostasis, but their functions and expressions in heart failure have yielded conflicting results [12].
Recent evidence suggests that both ionized calcium and vitamin D deficit are prevalent in cardiac surgical patients and are independently associated with the risk of MACCE [13,14,15,16]. Most of the existing data focused on vitamin D restoration, showing that perioperative vitamin D supplementation improves the postoperative outcomes after cardiac surgery [17,18,19]. On the other hand, no robust evidence exists regarding the safety and clinical efficacy of calcium salts in patients undergoing cardiac surgery [20]. Real-life data show that calcium salts are widely used in adult patients to support hemodynamics during CPB weaning. However, there is no widely accepted practice regarding the type of drug, optimal dose, and mode of administration, especially during bypass termination [21]. An exploration of these interconnected biomarkers within the clinical–pathophysiological context of cardiac performance, specifically left ventricular systolic function, would provide valuable insights into whether an imbalance in calcium or vitamin D levels might lead to adverse postoperative clinical outcomes.
The objective of this study was to investigate the potential impact of perioperative fluctuations in calcium or vitamin D levels on left ventricular EF, and to examine whether changes in EF correlate with adverse postoperative outcomes, including CPB time, aortic cross-clamp time, vasoactive inotropic score (VIS), and intensive care unit (ICU) length of stay.

2. Methods

This study, approved by the “Iuliu Hatieganu” University of Medicine Ethics Committee (approval number 259 on 28 September 2023), was conducted as a single-center, retrospective, single-arm, open-label, observational investigation. Considering the retrospective nature and minimal risk to participants, the Ethics Committee waived the need for individual consent. Two groups were stratified based on EF: EF < 50% and EF > 50%. EF measurements were consistently obtained before and 24 h after surgery by the attending cardiologist, utilizing the Simpson method during bedside transthoracic ultrasonography (TTE).
Inclusion criteria: all patients over 18 years old who underwent elective cardiovascular procedures requiring total anesthesia and cardiopulmonary bypass between 01 October 2021 and 28 February 2022 were enrolled. The study flow chart and design is presented in Figure 1. Twenty-two patients were excluded from this study. Exclusion criteria included urgent indications, unstable patients referred for major cardiovascular surgery, individuals with a history of hyperparathyroidism or active neoplasia, calcium or vitamin D supplements intake prior to hospitalization, inadequate blood collection protocols, inadequate TTE acquisitions, incomplete information for calculating the VIS score, and patients with a hospital length of stay less than 48 h (including those who expired or were transferred to other facilities). All the patients were followed up until the day of discharge.
Vitamin D levels were assessed 2 h prior to surgery. Ionized calcium levels were measured at predefined intervals: preoperatively, during CPB, immediately post-surgery (day 0), 24 h post-surgery (day 1), and upon discharge from the intensive care unit for patients with prolonged stays. All measurements were conducted from venous blood using the Biotek Microplate 50 TS washer (Agilent Technologies Inc., Santa Clara, CA, USA) and the 800 TS reader (Agilent Technologies Inc., Santa Clara, CA, USA). Vitamin D was determined using electrochemiluminescence, and ionized calcium was indirectly calculated from the value of serum calcium and total protein according to the following formula: Ca++ = (6 × Ca − PT/3):(PT + 6)3.
The clinical parameters were measured by two independent ICU physicians and were as follows: CPB time (minutes), aortic cross-clamp time (minutes), mechanical ventilation time (minutes), VIS intraoperative, day 0, and day 1, and ICU stay time (days). The VIS (a strong predictor of mortality and morbidity after cardiac surgery) was calculated with the following formula: VIS  =  dopamine dose [mcg/kg/min]  +  dobutamine [mcg/kg/min]  +  100 × epinephrine dose [mcg/kg/min]  +  10 × milrinone dose [mcg/kg/min]  +  10,000 × vasopressin [units/kg/min]  +  100 × norepinephrine dose [mcg/kg/min]), using the maximum dosing rates of vasoactive and inotropic medications (mcg/kg/min or IU/kg/min).
The primary outcome was a change in EF according to vitamin D and ionized calcium levels. The secondary outcome was a composite of postoperative clinical parameters: CPB time, aortic cross-clamp time, mechanical ventilation time, VIS (intraoperative, day 0, day 1), and ICU length of stay. For the patients included in the analysis, there was no loss of data.

Statistical Analyses

The continuous variables underwent assessment for normality using the Shapiro–Wilk test and were presented as mean ± standard deviation or median (interquartile range) as deemed suitable. Categorical variables were expressed as frequencies and percentages. Groups were compared using the chi-squared test, Student’s t-test, Wilcoxon signed rank test, or Mann–Whitney U test, as appropriate. Spearman’s correlation coefficients with p-values were calculated for the associations of the ejection fraction with vitamin D, ionized calcium, and the outcomes. The Pearson correlation was used to calculate the linear relationship between calcium levels and LVEF before surgery and after surgery and the change in EF (delta EF). All analyses were completed using R Statistical Software (version 4.1.1, Foundation for Statistical Computing, Vienna, Austria).

3. Results

3.1. Study Population

The characteristics of the 83 included patients are summarized in Table 1.
The mean age was 64.9 ± 8.5 years. The majority of procedures encompassed isolated CABG (N = 26, 31.3%), aortic valve procedures (N = 26, 31.3%), and mitral valve procedures (N = 12, 14.5%). The median preoperative vitamin D level was 15.8 (14.5–19.0) ng/mL. The levels of ionized calcium throughout the study period were 1.23 (1.20–1.25) mmol/L preoperatively, 1.14 (1.11–1.17) mmol/L during CPB, 1.20 (1.18–1.23) mmol/L at day 0, 1.21 (1.19–1.23) mmol/L at day 1, and 1.22 (1.20–1.25) mmol/L at discharge. There were no high ionized calcium alterations within the cohort, with a maximum value of 1.35 mmol/L found before surgery and with a significant drop-out during CPB, the lowest value being 1.01 mmol/L (p = 0.03), but with a similar behavior across the two groups (p = 0.4) (Figure 2).
The median CPB and aortic cross-clamp times were 100 min and 77 min, respectively. The median duration of mechanical ventilation was 3 h. Regarding hospitalization, the median lengths of stay in the ICU and hospital were 3 and 9 days, respectively. The median VIS showed a value of 4 intraoperatively, 3.5 on day 0, and 1.3 on day 1.
The median preoperative ejection fraction was 55.0 (48.5–60.0) %, with 21 (25.3%) of the patients having a perioperative ejection fraction of <50%. The median change from preoperative to postoperative ejection fraction was −2.0 (−10.0–0.0) % (Wilcoxon signed rank test: p < 0.001; Figure 2). There was no significant difference in the EF change across the two groups (p = 0.42).
The subjects with preoperative ejection fraction <50% had significantly lower preoperative vitamin D levels than those with preoperative ejection fraction ≥50% (p = 0.048); at the same time, these individuals (the low EF patients) were correlated with a poorer clinical outcome, as demonstrated in the Spearman correlation found in the subsection below. Other characteristics did not differ significantly according to the preoperative ejection fraction group. Neither did the trend in calcium differ according to these groups (Figure 3).

3.2. Correlations of Ejection Fraction with Vitamin D, Ionized Calcium, and Outcomes

Figure 4 depicts the Spearman’s correlation coefficients for the associations of ejection fraction with vitamin D, ionized calcium, and outcomes. The preoperative ejection fraction was significantly associated with CPB time (r = 0.22, p = 0.044) and aortic cross-clamp time (r = 0.24, p = 0.031). The postoperative ejection fraction, i.e., at day 1, was significantly and inversely associated with intraoperative VIS score (r = −0.28, p = 0.009), VIS score at day 0 (r = −0.25, p = 0.020), VIS score at day 1 (r = −0.23, p = 0.036), and ICU length of stay (r = −0.22, p = 0.047).
Finally, the change in ejection fraction (with a negative value corresponding to a decrease from preoperative to postoperative values) was significantly and inversely associated with CPB time (r = −0.23, p = 0.037), aortic cross-clamp time (r = −0.22, p = 0.044), intraoperative VIS score (r = −0.42, p < 0.001), VIS score at day 0 (r = −0.25, p = 0.024), mechanical ventilation time (r = −0.22, p = 0.047), and ICU length of stay (r = −0.23, p = 0.039). The significant correlations are summarized in Figure 5.
Regarding the Pearson correlation, there were no statistically significant correlations observed between the preoperative calcium levels and preoperative EF, nor between the postoperative calcium levels and postoperative EF (Figure 6). However, a weak-to-moderate statistically significant linear correlation (r = 0.26, p = 0.01) was demonstrated between the differences in the preoperative and postoperative values for these factors (Figure 6).

4. Discussion

The main findings of our study indicate that (1) fluctuations in perioperative ionized calcium levels did not affect left ventricular systolic function before and after major cardiovascular surgery requiring CPB. However, (2) there was a significant decrease in preoperative vitamin D levels among individuals with an EF of less than 50% (correlating further with a worse clinical progression). In terms of clinical significance, (3) a reduced EF (including preoperative, postoperative, and the change in EF) was correlated with all the studied clinical outcomes, including a longer CPB and aortic clamp time, a longer duration of mechanical ventilation, higher VIS, and a longer stay in the ICU. The change in EF was the only parameter which correlated with all the outcomes. It is necessary to acknowledge that the EF change was similar across the two groups; therefore, the outcomes were not driven by a potential lower change within the low EF group. Despite calcium’s traditional role as an inotropic agent, our findings suggest that its significance may not be as pronounced in cases where calcium levels remain within normal ranges (our cohort did not contain severe hypocalcemia cases <1.00 mmol/L). Furthermore, our study highlights the potential impact of vitamin D on post-surgical outcomes, drawing parallels with its role in chronic heart failure.
Our findings align with previously established data indicating that open-heart surgery triggers acute stress, which has been shown to negatively impact circulating concentrations of 25-hydroxyvitamin D (25(OH)D) [14,18,19,22]. The global prevalence of low vitamin D levels constitutes a significant health concern, with associations noted between low vitamin D and increased rates of all-cause and cardiovascular mortality. Notably, low levels of vitamin D are frequently observed preoperatively in patients undergoing cardiac surgery and are independently linked to the occurrence of major adverse cardiac and cerebrovascular events during hospitalization, as well as mortality in the months following cardiac surgery [23]. Further data showed that perioperative vitamin D supplementation protects against the immediate decrease in plasma 25(OH)D induced by open-heart surgery [17,18,19]. In fact, a recent systematic review comprising eight randomized controlled trials could show that six (75%) studies were found to be in favor of improvement in postoperative VIS, ICU stay, postoperative atrial fibrillation, IL-10 levels, or fewer cardiac adverse events [24]. Braun et al. found that 67.5% of patients had serum vitamin D levels below 60 nmol/L prior to cardiothoracic surgery [23]. The contractile properties of cardiac cells are primarily governed by the direct interaction between calcium and the contractile proteins, actin and myosin, as well as the intracellular handling of calcium. Additionally, extracellular calcium homeostasis, influenced by vitamin D levels, affects intracellular calcium and can indirectly impact cardiac cell contractility. Our study design was created from this concept, although to date only experimental data have shown that mice blocked for the vitamin D receptors developed myocardial hypertrophy and dysfunction, and there is still a substantial discrepancy between the outcome of experimental studies and clinical intervention trials [25]. There are a number of factors that influence/modulate circulating levels of vitamin D, including different geographic latitudes, skin pigmentation, availability of vitamin D food sources, age, sex, cultural habits, and lifestyle [26]. Furthermore, hypoparathyroidism, severe kidney disease, and liver insufficiency can affect serum 25-OH vitamin D levels [27]. Excessive intake of vitamin D has been shown to cause vitamin D toxicity, which can lead to anorexia, weight loss, polyuria, and heartbeat irregularities [28].
The effects of calcium on left ventricular function early after cardiopulmonary bypass come from old studies which measured the cardiac index invasively and acutely (immediately after surgery) [29,30]. To our knowledge, studies investigating calcium values measured at different time points which could correlate with the evolution of the EF at least 24 h after surgery do not exist. The reasons for our differing results could be either the characteristics of our studied cohort (stable, elective patients, disease severity, small sample size, small number of patients with EF below 25%, etc.), the relatively stable ionized calcium values (with no major fluctuations), the time point of sample collection, or the calcium supplementation intervention. It should also be noted that there was no consensus on the management of ionized calcium disorder in ICU. The authors believe future research should focus on postoperative cardiac performance biomarkers (negative or positive), with emphasis on severe hypocalcemia or vitamin D deficit, following clinical outcomes in patients who received correction. Our results underline the significance of left ventricular function, a physiological condition that should not be taken “as is”, but rather as a target for improvement in the initial days following cardiopulmonary resuscitation. Notably, the crucial role of mechanical support devices in bridging therapy was not addressed, but it is of equal importance [31]. Nevertheless, calcium and vitamin D remain two important drivers for cardiovascular performance and a more careful humoral screening could lead to a faster recovery of the cardiac patient. The application of these biomarkers extends beyond risk assessment to personalized medicine. By integrating biomarker data with clinical parameters, tailored perioperative care plans can be developed, optimizing surgical timing, anesthesia management, and postoperative care. This approach not only enhances patient safety and outcomes but also contributes to the efficient allocation of healthcare resources.
The authors also believe that the association of a lower EF with all perioperative clinical parameters should be interpreted with caution, as these correlations may have associative relationships rather than causative ones—i.e., a more morbid population (with a lower EF) could have a more unfavorable evolution after surgery. It is well established that patients with low LVEF face elevated risks of postoperative complications and mortality following cardiac procedures, with low EF serving as a key predictor of unfavorable outcomes, incorporated into all existing scoring systems [32,33]. Indeed, low preoperative LVEF is linked to a range of postoperative complications, including, but not limited to, low cardiac output syndrome, requirement for inotropic support, acute renal failure, lung congestion, pneumonia, atrial fibrillation, stroke, sepsis or endocarditis, and deep sternal wound infection, as well as bleeding necessitating reoperation and gastrointestinal bleeding [34,35,36]. In addition to these findings, our study introduces the concept of EF change, or “EF behavior”, which exhibited the most robust correlations with the outcomes, comprising two-thirds of all significant correlations, surpassing the predictive power of preoperative EF alone.
The variance in CPB time likely stems from an extended reperfusion phase following the release of the aortic cross-clamp, which is particularly evident in patients exhibiting severely impaired left ventricular function [37]. One study showed that, to minimize the occurrence of unfavorable adverse outcomes, it is recommended that the CPB/graft time and cumulative CPB time be kept below 56 min and 180 min, respectively [38]. Nonetheless, numerous surgeons opt to employ CPB due to the frequent occurrence of hemodynamic instability, ventricular arrhythmia-induced hypotension, or cardiac arrests, especially within CABG procedures. A speculation exists regarding the potential exacerbation of myocardial damage in patients with compromised left ventricles as a result of extracorporeal circulation. In our analysis, the CPB and aortic cross-clamp time were correlated mainly with the preoperative EF and the change in EF. On the other hand, the postoperative EF showed a significant correlation primarily with the VIS scores and the length of stay in the ICU. These factors forecasted the requirement for increased inotropic support among this cohort, linked with a prolonged duration of ICU stay.
This study has a few limitations. The single-center nature and small sample size (including the small number of patients in the low EF group) precluded definite conclusions from being drawn and meant that our findings should be seen as hypothesis-generating. The observational nature was also predisposed to residual confounding despite having accounted for a large number of confounders by means of multivariable adjustments. These may include other factors that may influence a lower EF after cardioplegia and CPB, such as myocardial stunning and reperfusion injury, especially since the control EF was measured 1–2 days after, and not later, or factors that may have influenced vitamin D or calcium levels, such as the chronic medication (with an impact on blood electrolytes), which was not taken into account. The prevalence of chronic kidney disease (comorbidity with a heavy influence on both vitamin D and ionized calcium levels) was similar across the two groups. The significant difference in CABG, with more procedures in the low EF group, could have influenced the evolution and recovery of EF in these patients, implicitly affecting the outcomes. Moreover, mitral insufficiency was not quantified—an important factor that could have affected LV systolic function, although the EF < 50% and >50% groups had similar clinical characteristics. Another significant limitation is that the postoperative levels of vitamin D were not assessed; a correlation with the preoperative values would have brought further insights into vitamin D behavior in patients with different EFs. Lastly, the strong correlations of low EF with clinical outcomes could also be caused by the worse evolution of these patients due to an intraoperative myocardial injury; thus, a longer hospitalization period, etc., would be expected, although our study showed that the trend is maintained with regard to both the preoperative EF and the change in EF.
In conclusion, the identification and application of biomarkers in major cardiovascular surgery are pivotal in advancing patient care. While traditional biomarkers, such as inflammatory markers and cardiac troponins, have been well documented in predicting surgical risk and guiding clinical decision making, the roles of calcium and vitamin D are also gaining recognition. Dysregulation of calcium levels can lead to significant perioperative complications, including arrhythmias and myocardial ischemia. Similarly, vitamin D, which is essential for calcium homeostasis, has been associated with cardiovascular health. Deficiencies in vitamin D have been linked to increased risk of cardiovascular diseases and adverse surgical outcomes. Current data indicate that the monitoring and correcting of calcium and vitamin D levels perioperatively can improve patient outcomes by reducing complications and enhancing recovery [39,40,41]. Integrating the management of calcium and vitamin D with other biomarker strategies enhances the precision and efficacy of cardiovascular surgical interventions, fostering a more holistic approach to patient care. As research continues to evolve, a comprehensive biomarker panel that includes both traditional biomarkers and calcium and vitamin D will be crucial in advancing the field of cardiovascular surgery.

5. Conclusions

The evolution of left ventricular systolic function before and after major cardiovascular surgery requiring CPB was not influenced by the fluctuations of perioperative ionized calcium values, while vitamin D may play a role in those with low EF. On the other hand, a lower EF was associated with all the studied clinical outcomes (CPB time, aortic clamp time, mechanical ventilation time, VIS, and ICU length of stay). The importance of biomarkers with an effect on cardiac inotropic function deserves further research.

Author Contributions

Conceptualization, A.Ş., C.B., A.A. and A.D.B.; methodology, A.Ş., A.G.S., A.M., I.C.B. and A.D.B.; software, A.A.; validation, A.Ş. and N.T.; investigation, A.Ş., C.B., A.A., I.C.B. and N.T.; resources, A.Ş., C.B., R.M.P. and A.G.S.; data curation, A.Ş., C.B., R.M.P. and A.A.; writing—original draft preparation, A.Ş.; writing—review and editing, C.B., I.C.B., A.A., A.M. and A.D.B.; visualization, A.A. and A.D.B.; supervision, C.B., I.C.B. and A.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca (approval number 259 on 28 September 2023).

Informed Consent Statement

Patient consent was waived by the Ethics Committee due to the retrospective nature and minimal risk to participants.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Conflicts of Interest

The authors report no financial relationships or conflicts of interest regarding the content herein.

Abbreviations

Major adverse cardiac and cerebrovascular events, MACCE; cardiopulmonary bypass, CPB; ejection fraction; EF; left ventricular, LV; vasoactive inotropic score, VIS; intensive care unit, ICU; transthoracic echocardiography, TTE.

References

  1. Gaudino, M.; Dangas, G.D.; Angiolillo, D.J.; Brodt, J.; Chikwe, J.; DeAnda, A.; Hameed, I.; Rodgers, M.L.; Sandner, S.; Sun, L.Y.; et al. Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement from the American Heart Association. Circulation 2023, 148, 442–454. [Google Scholar] [CrossRef] [PubMed]
  2. Urso, C.; Brucculeri, S.; Caimi, G. Acid-base and electrolyte abnormalities in heart failure: Pathophysiology and implications. Heart Fail. Rev. 2015, 20, 493–503. [Google Scholar] [CrossRef] [PubMed]
  3. Lomivorotov, V.V.; Leonova, E.A.; Belletti, A.; Shmyrev, V.A.; Landoni, G. Calcium administration during weaning from cardiopulmonary bypass: A narrative literature review. J. Cardiothorac. Vasc. Anesth. 2020, 34, 235–244. [Google Scholar] [CrossRef] [PubMed]
  4. Carsetti, A.; Bignami, E.; Cortegiani, A.; Donadello, K.; Donati, A.; Foti, G.; Grasselli, G.; Romagnoli, S.; Antonelli, M.; DEBlasio, E.; et al. Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: State-of-the-art and expert consensus. Minerva. Anestesiol. 2021, 87, 714–732. [Google Scholar] [CrossRef] [PubMed]
  5. Faritous, S.Z.; Zaree, S.R.; Morshedizad, Z.; Jalali, A.H.; Mahani, S.M.; Gholampour, M. The effect of calcium gluconate administration during cardiopulmonary bypass on hemodynamic variables in infants undergoing open-heart surgery. Egypt. Heart J. 2022, 74, 29. [Google Scholar] [CrossRef]
  6. Zhao, Z.H.; Jin, C.L.; Jang, J.H.; Wu, Y.N.; Kim, S.J.; Jin, H.H.; Cui, L.; Zhang, Y.H. Assessment of myofilament Ca2+ sensitivity underlying cardiac excitation-contraction coupling. J. Vis. Exp. 2016, 114, e54057. [Google Scholar] [CrossRef]
  7. Witte, K.K.; Byrom, R.; Gierula, J.; Paton, M.F.; Jamil, H.A.; Lowry, J.E.; Gillott, R.G.; Barnes, S.A.; Chumun, H.; Kearney, L.C.; et al. Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study. J. Am. Coll. Cardiol. 2016, 67, 2593–2603. [Google Scholar] [CrossRef] [PubMed]
  8. Wang, Y.; Ma, H.; Hao, X.; Yang, J.; Chen, Q.; Lu, L.; Zhang, R. Low serum calcium is associated with left ventricular systolic dysfunction in a Chinese population with coronary artery disease. Sci. Rep. 2016, 6, 22283. [Google Scholar] [CrossRef]
  9. Lutsey, P.L.; Alonso, A.; Michos, E.D.; Loehr, L.R.; Astor, B.C.; Coresh, J.; Folsom, A.R. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 2014, 100, 756–764. [Google Scholar] [CrossRef]
  10. Li, J.; Wu, N.; Dai, W.; Jiang, L.; Li, Y.; Li, S.; Wen, Z. Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes. Cardiovasc. Diabetol. 2016, 15, 140. [Google Scholar] [CrossRef]
  11. Cubbon, R.M.; Thomas, C.H.; Drozd, M.; Gierula, J.; Jamil, H.A.; Byrom, R.; Barth, J.H.; Kearney, M.T.; Witte, K.K.A. Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure. J. Nephrol. 2015, 28, 209–215. [Google Scholar] [CrossRef] [PubMed]
  12. Mazeto, I.; Okoshi, K.; Silveira, C.; Sant’Ana, P.; da Silva, V.; Mota, G.; de Souza, S.; Vileigas, D.; Padovani, C.; Cicogna, A. Calcium homeostasis behavior and cardiac function on left ventricular remodeling by pressure overload. Braz. J. Med. Biol. Res. 2021, 54, e10138. [Google Scholar] [CrossRef] [PubMed]
  13. Ștef, A.; Bodolea, C.; Bocșan, I.C.; Vesa, Ș.C.; Pop, R.M.; Cainap, S.S.; Achim, A.; Antal, O.; Tintiuc, N.; Buzoianu, A.D. Investigating Potential Correlations between Calcium Metabolism Biomarkers and Periprocedural Clinical Events in Major Cardiovascular Surgeries: An Exploratory Study. J. Clin. Med. 2024, 13, 2242. [Google Scholar] [CrossRef] [PubMed]
  14. Zittermann, A.; Kuhn, J.; Dreier, J.; Knabbe, C.; Gummert, J.F.; Börgermann, J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur. Heart J. 2013, 34, 1358–1364. [Google Scholar] [CrossRef] [PubMed]
  15. Bi, S.; Liu, R.; Li, J.; Chen, S.; Gu, J. The Prognostic Value of Calcium in Post-Cardiovascular Surgery Patients in the Intensive Care Unit. Front. Cardiovasc. Med. 2021, 8, 733528. [Google Scholar] [CrossRef]
  16. Ney, J.; Heyland, D.K.; Amrein, K.; Marx, G.; Grottke, O.; Choudrakis, M.; Autschbach, T.; Hill, A.; Meybohm, P.; Benstoem, C.; et al. The relevance of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration for postoperative infections and postoperative organ dysfunctions in cardiac surgery patients: The eVIDenCe study. Clin. Nutr. 2019, 38, 2756–2762. [Google Scholar] [CrossRef] [PubMed]
  17. Barker, T.; May, H.T.; Doty, J.R.; Lappe, D.L.; Knowlton, K.U.; Carlquist, J.; Konery, K.; Inglet, S.; Chisum, B.; Galenko, O.; et al. Vitamin D supplementation protects against reductions in plasma 25-hydroxyvitamin D induced by open-heart surgery: Assess-d trial. Physiol. Rep. 2021, 9, e14747. [Google Scholar] [CrossRef] [PubMed]
  18. Talasaz, A.H.; Salehiomran, A.; Heidary, Z.; Gholami, K.; Aryannejad, H.; Jalali, A.; Daei, M. The effects of vitamin D supplementation on postoperative atrial fibrillation after coronary artery bypass grafting in patients with vitamin D deficiency. J. Card. Surg. 2022, 37, 2219–2224. [Google Scholar] [CrossRef] [PubMed]
  19. Jelveh-Moghaddam, H.; Fani, K.; Hekmat, M.; Azari, A. The effects of vitamin D3 in pediatric patients undergoing congenital heart surgery. J. Cell. Mol. Anesth. 2020, 5, e149624. [Google Scholar]
  20. Lomivorotov, V.; Ponomarev, D.; Boboshko, V.; Shmyrev, V.; Ismoilov, S.; Efremov, S.; Kamenshchikov, N.; Akselrod, B.; Pasyuga, V.; Urusov, D.; et al. Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial. Contemp. Clin. Trials Commun. 2021, 23, 100835. [Google Scholar] [CrossRef]
  21. Lomivorotov, V.V.; Guvakov, D.; Belletti, A.; Boboshko, V.; Shmyrev, V.; Kunst, G.; Stoppe, C.; Akselrod, B.; Kamenshchikov, N.; Efremov, S.; et al. Current Practice of Calcium Use During Cardiopulmonary Bypass Weaning: Results of an International Survey. J. Cardiothorac. Vasc. Anesth. 2020, 34, 2111–2115. [Google Scholar] [CrossRef]
  22. Tasdighi, E.; Hekmat, M.; Beheshti, M.; Baghaei, R.; Mirhosseini, S.M.; Torbati, P.; Pourmotahari, F.; Foroughi, M. Vitamin D Treatment Attenuates Heart Apoptosis After Coronary Artery Bypass Surgery: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. J. Cardiovasc. Pharmacol. Ther. 2020, 25, 338–345. [Google Scholar] [CrossRef] [PubMed]
  23. Braun, L.A.; Spitzer, O.; Levkovich, B.; Bailey, M.; Stanguts, C.; Hose, L.; Rosenfeldt, F. Prevalence of vitamin D deficiency prior to cardiothoracic surgery. Heart Lung. Circ. 2014, 23, 978–980. [Google Scholar] [CrossRef] [PubMed]
  24. Das, S.; Bej, P. Effect of Vitamin D Supplementation on Postoperative Outcomes in Cardiac Surgery Patients: A Systematic Review. J. Card. Crit. Care TSS 2022, 6, 195–200. [Google Scholar] [CrossRef]
  25. Tappia, P.S.; Lopez, R.; Fitzpatrick-Wong, S.; Ramjiawan, B. Understanding the Role of Vitamin D in Heart Failure. Rev. Cardiovasc. Med. 2023, 24, 111. [Google Scholar] [CrossRef] [PubMed]
  26. Dominguez, L.J.; Farruggia, M.; Veronese, N.; Barbagallo, M. Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment. Metabolites 2021, 11, 255. [Google Scholar] [CrossRef] [PubMed]
  27. Al-Badr, W.; Martin, K.J. Vitamin D and kidney disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1555–1560. [Google Scholar] [CrossRef]
  28. Marcinowska-Suchowierska, E.; Kupisz-Urbańska, M.; Łukaszkiewicz, J.; Płudowski, P.; Jones, G. Vitamin D Toxicity-A Clinical Perspective. Front. Endocrinol. 2018, 9, 550. [Google Scholar] [CrossRef]
  29. DeHert, S.G.; Ten Broecke, P.W.; De Mulder, P.A.; Rodrigus, I.E.; Haenen, L.R.; Boeckxstaens, C.J.; Vermeyen, K.M.; Gillebert, T.C.; Moulijn, A.C. Effects of calcium on left ventricular function early after cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 1997, 11, 864–869. [Google Scholar] [CrossRef]
  30. Shapira, N.; Schaff, H.V.; White, R.D.; Pluth, J.R. Hemodynamic effects of calcium chloride injection following cardiopulmonary bypass: Response to bolus injection and continuous infusion. Ann. Thorac. Surg. 1984, 37, 133–140. [Google Scholar] [CrossRef]
  31. Nersesian, G.; Ott, S.; Fardman, A.; Lanmueller, P.; Lewin, D.; Bernhardt, A.; Emrich, F.; Faerber, G.; Szabó, G.; Oezkur, M.; et al. Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients after Cardiac Procedures: Selection Algorithm and Weaning Strategies. Life 2023, 13, 2045. [Google Scholar] [CrossRef] [PubMed]
  32. Topkara, V.K.; Cheema, F.H.; Kesavaramanujam, S.; Mercando, M.L.; Cheema, A.F.; Namerow, P.B.; Argenziano, M.; Naka, Y.; Oz, M.C.; Esrig, B.C. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005, 112 (Suppl. 9), I344–I350. [Google Scholar] [CrossRef] [PubMed]
  33. Hamad, M.A.; van Straten, A.H.; Schönberger, J.P.; ter Woorst, J.F.; de Wolf, A.M.; Martens, E.J.; van Zundert, A.A. Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: Comparison with a matched general population. J. Cardiothorac. Surg. 2010, 5, 29. [Google Scholar] [CrossRef] [PubMed]
  34. Butterworth, J.F.; Legault, C.; Royster, R.L.; Hammon, J.W., Jr. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth. Analg. 1998, 86, 461–467. [Google Scholar] [CrossRef] [PubMed]
  35. Bove, T.; Calabrò, M.G.; Landoni, G.; Aletti, G.; Marino, G.; Crescenzi, G.; Rosica, C.; Zangrillo, A. The incidence and risk of acute renal failure after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2004, 18, 442–445. [Google Scholar] [CrossRef] [PubMed]
  36. Allou, N.; Bronchard, R.; Guglielminotti, J.; Dilly, M.P.; Provenchere, S.; Lucet, J.C.; Laouénan, C.; Montravers, P. Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score. Crit. Care Med. 2014, 42, 1150–1156. [Google Scholar] [CrossRef] [PubMed]
  37. Filsoufi, F.; Rahmanian, P.B.; Castillo, J.G.; Chikwe, J.; Kini, A.S.; Adams, D.H. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann. Thorac. Surg. 2007, 84, 808–816. [Google Scholar] [CrossRef]
  38. Madhavan, S.; Chan, S.P.; Tan, W.C.; Eng, J.; Li, B.; Luo, H.D.; Teoh, L.K. Cardiopulmonary bypass time: Every minute counts. J. Cardiovasc. Surg. 2018, 59, 274–281. [Google Scholar] [CrossRef] [PubMed]
  39. Reid, I.R.; Birstow, S.M.; Bolland, M.J. Calcium and Cardiovascular Disease. Endocrinol. Metab. 2017, 32, 339–349. [Google Scholar] [CrossRef]
  40. Rohrmann, S.; Garmo, H.; Malmström, H.; Hammar, N.; Jungner, I.; Walldius, G.; Van Hemelrijck, M. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study. Atherosclerosis 2016, 251, 85–93. [Google Scholar] [CrossRef]
  41. Pilz, S.; März, W.; Cashman, K.D.; Kiely, M.E.; Whiting, S.J.; Holick, M.F.; Grant, W.B.; Pludowski, P.; Hiligsmann, M.; Trummer, C.; et al. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front. Endocrinol. 2018, 9, 373. [Google Scholar] [CrossRef] [PubMed]
Jpm 14 00850 g001
Figure 1. Study flow chart.
Figure 1. Study flow chart.
Jpm 14 00850 g001
Jpm 14 00850 g002
Figure 2. Change in ejection fraction from preoperative to day 1.
Figure 2. Change in ejection fraction from preoperative to day 1.
Jpm 14 00850 g002
Jpm 14 00850 g003
Figure 3. Trend in ionized calcium during the study period, according to preoperative ejection fraction (EF) group.
Figure 3. Trend in ionized calcium during the study period, according to preoperative ejection fraction (EF) group.
Jpm 14 00850 g003
Jpm 14 00850 g004
Figure 4. Spearman’s correlation coefficients for the associations of ejection fraction with vitamin D, ionized calcium, and outcomes. Correlation coefficients are given. Statistically significant correlation coefficients (p < 0.05) are indicated by *.
Figure 4. Spearman’s correlation coefficients for the associations of ejection fraction with vitamin D, ionized calcium, and outcomes. Correlation coefficients are given. Statistically significant correlation coefficients (p < 0.05) are indicated by *.
Jpm 14 00850 g004
Jpm 14 00850 g005
Figure 5. Significant correlations between EF and outcomes (preoperative EF sub-figures (A,B), postoperative EF subfigures (C–F), and change in EF subfigures (G–L)). EF, ejection fraction; CPB, cardiopulmonary bypass; VIS, vasoinotropic score.
Figure 5. Significant correlations between EF and outcomes (preoperative EF sub-figures (A,B), postoperative EF subfigures (C–F), and change in EF subfigures (G–L)). EF, ejection fraction; CPB, cardiopulmonary bypass; VIS, vasoinotropic score.
Jpm 14 00850 g005
Jpm 14 00850 g006
Figure 6. Correlations between preoperative (first panel), postoperative (middle panel), and differences in ejection fraction and calcium levels (last panel). There is no linear relationship between the calcium levels and LVEF before and after surgery, but the decrease in calcium values is weakly to moderately directly proportional to the decrease in LVEF values (r = 0.26, p = 0.01).
Figure 6. Correlations between preoperative (first panel), postoperative (middle panel), and differences in ejection fraction and calcium levels (last panel). There is no linear relationship between the calcium levels and LVEF before and after surgery, but the decrease in calcium values is weakly to moderately directly proportional to the decrease in LVEF values (r = 0.26, p = 0.01).
Jpm 14 00850 g006
Table 1. Population and surgical procedure characteristics as divided per preoperative low EF group (cut-off < 50%) and normal EF (cut-off ≥ 50%) group. BMI, body mass index; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; ASD, atrial septal defect; CPB, cardiopulmonary bypass; ICU, intensive care unit; VIS, vasoinotropic score.
Table 1. Population and surgical procedure characteristics as divided per preoperative low EF group (cut-off < 50%) and normal EF (cut-off ≥ 50%) group. BMI, body mass index; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; ASD, atrial septal defect; CPB, cardiopulmonary bypass; ICU, intensive care unit; VIS, vasoinotropic score.
VariableAll (N = 83)EF < 50% (N = 21)EF ≥ 50% (N = 62)p-Value
Age64.9 ± 8.564.0 ± 11.165.2 ± 7.50.633
BMI28.4 (25.2–31.6)27.0 (23.7–30.4)29.1 (25.4–31.8)0.150
Hypertension47 (56.6%)12 (57.1%)35 (56.4%)0.632
Diabetes Mellitus27 (32.5%)8 (38%)19 (30.6%)0.110
Chronic Anemia16 (19.3%)4 (19%)12 (19.3%)0.238
COPD14 (16.9%)4 (19%)10 (16.1%)0.192
Chronic Kidney Disease23 (27.7%)6 (28.6%)17 (27.4%)0.654
Procedure 0.454
Isolated CABG26 (31.3%)11 (52.4%)15 (24.2%)0.016
Aortic valve procedure26 (31.3%)6 (28.6%)20 (32.3%)0.753
Mitral valve procedure12 (14.5%)1 (4.76%)11 (17.7%)0.144
Complex valve procedure4 (4.82%)1 (4.76%)3 (4.84%)0.989
CABG + valve procedure5 (6.02%)1 (4.76%)4 (6.45%)0.779
Bentall procedure3 (3.61%)1 (4.76%)2 (3.23%)0.744
Aortic valve and ascending aorta repair3 (3.61%)0 (0.00%)3 (4.84%)1.000
Aortic aneurysm repair2 (2.41%)0 (0.00%)2 (3.23%)1.000
ASD correction2 (2.41%)0 (0.00%)2 (3.23%)1.000
Atrial fibrillation13 (15.7%)1 (4.76%)12 (19.4%)0.168
Pacemaker2 (2.41%)1 (4.76%)1 (1.61%)0.444
Vitamin D Preoperative, ng/mL15.8 (14.5–19.0)15.0 (14.4–16.3)16.1 (14.6–20.1)0.048
Calcium Preoperative, mmol/L1.23 (1.20–1.25)1.24 (1.21–1.26)1.23 (1.19–1.25)0.386
Calcium During CPB, mmol/L1.14 ± 0.051.13 ± 0.061.14 ± 0.050.403
Calcium Day 0, mmol/L1.19 ± 0.051.20 ± 0.051.19 ± 0.050.518
Calcium Day 1, mmol/L1.21 (1.19–1.23)1.21 (1.19–1.23)1.21 (1.19–1.23)0.765
Calcium At Discharge, mmol/L1.22 (1.20–1.25)1.21 (1.20–1.26)1.22 (1.20–1.24)0.804
CPB time, min100 (67.5–128)100 (59.0–113)101 (77.2–154)0.154
Aortic cross-clamp time, min77.0 (47.0–92.0)75.0 (34.0–84.0)77.0 (55.0–104)0.178
Mechanical ventilation, hours5.00 (3.00–8.00)4.00 (3.00–8.00)5.00 (3.00–8.00)0.630
ICU length of stay, days3.00 (2.00–4.00)3.00 (2.00–4.00)3.00 (2.00–4.00)0.652
Hospital length of stay, days9.00 (8.00–12.0)8.00 (8.00–12.0)9.00 (8.00–11.8)0.526
VIS, intraoperative4.00 (2.00–7.55)3.00 (2.00–6.25)4.00 (2.00–7.80)0.821
VIS, day 03.50 (0.00–6.05)3.90 (2.00–7.00)3.25 (0.00–5.88)0.536
VIS, day 11.30 (0.00–3.38)2.20 (0.00–4.00)1.23 (0.00–3.00)0.205
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ștef, A.; Bodolea, C.; Bocșan, I.C.; Achim, A.; Tintiuc, N.; Pop, R.M.; Solomonean, A.G.; Manea, A.; Buzoianu, A.D. Perioperative Modulation of Left Ventricular Systolic Performance: A Retrospective Study on Ionized Calcium and Vitamin D in Cardiac Surgery Patients. J. Pers. Med. 2024, 14, 850. https://doi.org/10.3390/jpm14080850

AMA Style

Ștef A, Bodolea C, Bocșan IC, Achim A, Tintiuc N, Pop RM, Solomonean AG, Manea A, Buzoianu AD. Perioperative Modulation of Left Ventricular Systolic Performance: A Retrospective Study on Ionized Calcium and Vitamin D in Cardiac Surgery Patients. Journal of Personalized Medicine. 2024; 14(8):850. https://doi.org/10.3390/jpm14080850

Chicago/Turabian Style

Ștef, Adrian, Constantin Bodolea, Ioana Corina Bocșan, Alexandru Achim, Nadina Tintiuc, Raluca Maria Pop, Aurelia Georgeta Solomonean, Alexandru Manea, and Anca Dana Buzoianu. 2024. "Perioperative Modulation of Left Ventricular Systolic Performance: A Retrospective Study on Ionized Calcium and Vitamin D in Cardiac Surgery Patients" Journal of Personalized Medicine 14, no. 8: 850. https://doi.org/10.3390/jpm14080850

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop